Telomerase activity in renal cell carcinoma

Cancer

Volumn 83, Issue 4, 1998, Pages 760-766

  Yoshida, Ken Ichiro ^a   Sakamoto, Shu Ichi ^a   Sumi, Shuhei ^a   Higashi, Yotsuo ^a   Kitahara, Satoshi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Clinicopathologic parameters; Renal cell carcinoma; Telomerase activity; TNM classification

Indexed keywords

BIOCHEMICAL MARKER; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; CARCINOMA, RENAL CELL; FEMALE; FLUORESCENCE; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERASE;

EID: 0031841125     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980815)83:4<760::AID-CNCR19>3.0.CO;2-Q     Document Type: Article

References (42)

1. Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma: prognostic significance of morphologic parameters in 121 cases. Cancer 1988;61:1639-51.
2. Strohmeyer T, Ackermann R. Classic and modern prognostic indicators in renal cell carcinoma. Urol Int 1991;47:203-12.
3. Lanigan D, McLean PA, Murphy DM, Donovan MG, Curran B, Leader M. Ploidy and prognosis in renal carcinoma. Br J Urol 1993;71:21-4.
4. Grignon DJ, El-Naggar A, Green LK, Ayala AG, Ro JY, Swanson DA, et al. DNA flow cytometry as a predictor of outcome of stage I renal cell carcinoma. Cancer 1989;63:1161-5.
5. Yao M, Shuin T, Misaki H, Kubota Y. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-I) genes in primary human renal cancer. Cancer Res 1988;48: 6753-7.
6. Mydlo JH, Michaeli J, Cordon-Cardo C, Goldenberg AS, Heston WDW, Fair WR. Expression of transforming growth factor α and epidermal growth factor receptor messenger RNA in neoplastic and non-neoplastic human kidney. Cancer Res 1989;49:6753-7.
7. Sargent ER, Gomella LG, Belldegrun A, Linehan WM, Kasid A. Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma. J Urol 1989; 142:1364-8.
8. Reubi JC, Kvols L. Somatostatin receptors in human renal cell carcinomas. Cancer Res 1992;52:6074-8.
9. Uhlman DL, Nguyen P, Manvel JC, Zhang G, Hagen K, Fraley E, et al. Epidermal growth factor receptor and transforming growth factor α expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis. Clin Cancer Res 1995;1:913-20.
10. Ryu MS. Telomeres, telomerase and immortality. J Natl Cancer Inst 1995;87:884-94.
11. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-73.
12. Olovnik AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1978;41:181-90.
13. Zakian VA. Telomeres: beginning to understand the end. Science 1995;270:1601-7.
14. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995;55: 2533-6.
15. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, et al. Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-62.
16. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, et al. Telomerase activity in small-cell and non small-cell lung cancers. J Natl Cancer Inst 1995;87:895-901.
17. Hiyama E, Gollahon L, Kataoka T, Kuori K, Yokoyama T, Gazdar AF, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996;88:116-22.
18. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinoma. Cancer Res 1995;55:2234-6.
19. Lin Y, Miyamoto H, Fujinami K, Uemura H, Hosaka M, Iwasaki Y, et al. Telomerase activity in human bladder cancer. Clin Cancer Res 1996;2:929-32.
20. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995;1:249-55.
21. Kyo S, Ueno H, Kanaya T, Inoue M. Telomerase activity in gynecological tumors. Clin Cancer Res 1996;2:2023-8.
22. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K. Telomerase reactivation in leukemia cells. Int J Oncol 1996;8:417-21.
23. Ohyashiki JH, Ohyashiki K, Sano T, Toyama K. Non-radioactive semi-quantitative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 1996;87:329-31.
24. Ohyashiki JH, Ohyashiki K, Toyama K, Shay JWA. A non-radioactive fluorescence-based telomeric repeat amplification protocol to detect and quantitate telomerase activity. Trends Genet 1996;12:395-6.
25. Hisatomi H, Kawamoto Y, Ohmura Y. Detection of telomerase activity in hepatocellular carcinoma by fluorescence-based TRAP method. Int Hepatol Commun 1996;6:29-35.
26. Guinan P, Sobin LH, Algaba F, Badellino F, Kameyama S, MacLennan G, et al. TNM staging of renal cell carcinoma. Workgroup No. 3. Cancer 1997;80:992-3.
27. Störkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bosteick DG, et al. Classification of renal cell carcinoma. Workgroup No. 1. Cancer 1997;80:987-9.
28. Furhman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1968;44:3448-53.
29. Medeiros LJ, Jones EC, Aizawa S, Aldape HC, Cheville JC, Goldstein NS, et al. Grading of renal cell carcinoma. Workgroup No. 2. Cancer 1997;80:990-1.
30. Makarov LL, Lejnine S, Bedoyan J, Langmore J. Nucleosomal organization of telomere-specific chromatin in rat. Cell 1993;73:775-87.
31. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 1994;13: 4953-62.
32. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995;17:4240-8.
33. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, Depinho RA, et al. Telomerase shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91:25-34.
34. Wang SS, Zakian VA. Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature 1990;345:456-8.
35. Biessmann H, Mason JM, Ferry K, d'Hulst M, Valgeirsdotti K, Traverse KL, et al. Addition of telomere-associated HeT DNA sequences "heals" broken chromosome ends in Drosophila. Cell 1990;61:663-73.
36. Biessmann H, Valgeirsdottir K, Lofsky A, Chin C, Ginther B, Levis RW, et al. HeT, a transposable element specifically involved in "healing" broken chromosome ends in Drosophila melanogaster. Mol Cell Biol 1992;12:3910-8.
37. Levis RW, Ganesan R, Houtchens K, Tolar LA, Shenn F. Transposons in place of telomeric repeats at a Drosophila telomere. Cell 1993;75:1083-93.
38. Hohaus S, Cavallo S, Bellacosa A, Genuardi M, Galli J, Cadoni G, et al. Telomerase activity in human laryngeal squamous cell carcinoma. Clin Cancer Res 1996;2:1895-900.
39. Fetter TR, Snyder AI. Survival study on renal cell carcinoma. Surg Gynecol Obstet 1963;117:7-9.
40. Mostofi FK. Pathology and spread of renal cell carcinoma. In: King JS Jr., editor. Renal neoplasia. London: J and A Churchill, Ltd., 1967:41-85.
41. Ekter R, Nesland JM, Anderson A, Johannessen JV. Prognostic factors in renal cell carcinoma. Histol Histopathol 1986; 1:255-70.
42. Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ. Stage I renal cell carcinoma, a clinicopathologic study of 82 cases. Am J Surg Pathol 1993;17:275-86.